Mualliflar

  • Sheranov A.M.

##semicolon##

rezistent arterial gipertenziya, patofiziologiya, tashxis, davolash, arterial qattiqlik, endotelial disfunktsiya, renin-angiotenzin-aldosteron tizimi, buyrak denervatsiyasi.

##submission.citations##

Litvinova, M. S., Khaisheva, L. A., & Shlyk, S. V. (2020). Rezistentnaya gipertenziya: fokus na porazhenie sosudistogo rusla (Resistant hypertension: focus on vascular lesions). Yujno-Rossiyskiy zhurnal terapevticheskoy praktiki (South Russian Journal of Therapeutic Practice), 1(3), 16-26. DOI: 10.21886/ 2712-8156-2020-1-3-16-26

Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison Himmelfarb, C. R., … & Smith, S. M. (2018). Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension, 72(5), e53–e90. DOI: 10.1161/HYP.0000 000000000084

Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., … & Coca, A. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021–3104. DOI: 10.1093/eurheartj/ ehy339

Bhatt, H., Siddiqui, M., Judd, E., Oparil, S., & Calhoun, D. A. (2016). Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement. Journal of the American Society of Hypertension, 10(6), 493–499. DOI: 10.1016/j.jash.2016. 03.186

Messerli, F. H., Ventura, H. O., & Amodeo, C. (1985). Osler’s maneuver and pseudohypertension. New England Journal of Medicine, 312(26), 1548–1551. DOI: 10.1056/NEJM198506133122405

Salles, G. F., Cardoso, C. R., & Muxfeldt, E. S. (2008). Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Archives of Internal Medicine, 168(21), 2340–2346. DOI: 10.10 01/archinte.168.21.2340

Franklin, S. S., Thijs, L., Asayama, K., Li, Y., Hansen, T. W., Boggia, J., … & Staessen, J. A. (2016). The cardiovascular risk of white-coat hypertension. Journal of the American College of Cardiology, 68( 19), 2033–2043. DOI: 10.1016/j.jacc.2016.08.035

Hameed, M. A., Tebbit, L., Jacques, N., Thomas, M., & Dasgupta, I. (2016). Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic. Journal of Human Hypertension, 30(2), 83–89. DOI: 10.1038/jhh.2015.38

Achelrod, D., Wenzel, U., & Frey, S. (2015). Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. American Journal of Hypertension, 28(3), 355–361. DOI: 10.1093/ajh/hpu151

Noubiap, J. J., Nansseu, J. R., Nyaga, U. F., Sime, P. S., Francis, I., & Bigna, J. J. (2019). Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients. Heart, 105(2), 98–105. DOI: 10.1136/heartjnl-2018-313599

Daugherty, S. L., Powers, J. D., Magid, D. J., Tavel, H. M., Masoudi, F. A., Margolis, K. L., … & O’Connor, P. J. (2012). Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation, 125(13), 1635–1642. DOI: 10.1161/CIRCULATION AHA.111.068064

Rimoldi, S. F., Scherrer, U., & Messerli, F. H. (2014). Secondary arterial hypertension: when, who, and how to screen? European Heart Journal, 35(19), 1245–1254. DOI: 10.1093/eurheartj/eht534

Egan, B. M., Zhao, Y., & Axon, R. N. (2011). Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation, 124(9), 1046–1058. DOI: 10.1161/CIRCULATION-AHA.111.030189

Sim, J. J., Bhandari, S. K., Shi, J., Reynolds, K., Calhoun, D. A., & Kalantar-Zadeh, K. (2015). Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney International, 88(3), 622–632. DOI: 10.1038/ki.2015.142

Rimoldi, S. F., Messerli, F. H., Bangalore, S., & Scherrer, U. (2015). Resistant hypertension: what the cardiologist needs to know. European Heart Journal, 36(40), 2686–2695[119]. DOI: 10.1093/eurhear tj/ehv392

Egan, B. M., Laken, M. A., Donovan, J. L., Woolson, R. F., Jazwinski, J., & Wagner, C. S. (2016). Blood pressure control provides less cardiovascular protection in adults with than without apparent treatment-resistant hypertension. Journal of Clinical Hypertension, 18(8), 817–824. DOI: 10.1111/jch.12773

Kline, G. A., Prebtani, A. P. H., Leung, A. A., & Schiffrin, E. L. (2017). Primary aldosteronism: a common cause of resistant hypertension. Canadian Medical Association Journal (CMAJ), 189(22), E773–E778. DOI: 10.1503/cmaj.161486

Williams, B., MacDonald, T. M., Morant, S., Webb, D. J., Sever, P., McInnes, G., … & Caulfield, M. J. (2015). Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2). The Lancet, 386(10008), 2059–2068. DOI: 10.1016/S0140-6736(15)00257-3

Lee, C. J., Ihm, S. H., Shin, D. H., Park, S. H., Kim, T. H., Seong, E. Y., … & Kim, C. J. (2025). Spironolactone vs amiloride for resistant hypertension: a randomized clinical trial. JAMA, 333(23), 2073–2082. DOI: 10.1001/jama.2025.5129

Cardoso, C. R. L., Salles, G. C., & Salles, G. F. (2019). Prognostic impact of aortic stiffness in patients with resistant hypertension. Hypertension, 73(3), 728–735. DOI: 10.1161/ hypertensionaha. 118.12367

Omboni, S., & Ferrari, R. (2015). The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Current Hypertension Reports, 17(4), 535. DOI: 10.1007/s11906-015-0 535-3

Sheranov A. M. Diagnosis of functional disorders of the gastrointestinal tract in patients with constipation and choice of treatment tactics (literature review) //Журнал гуманитарных и естественных наук. – 2025. – №. 20. – С. 109-116.

Sheranov A. M. Modern aspects of the etiology, pathogenesis, and individualized therapy of peptic ulcer disease //Вестник Ассоциации Пульмонологов Центральной Азии. – 2025. – Т. 8. – №. 3. – С. 173-180.

Шеранов А. М., Таджиев Ф. С., Джаббарова Н. М. Особенности клинического течения хронической обструктивной болезни легких у больных гериатрического возраста в Самаркандском регионе //Тюменский медицинский журнал. – 2013. – Т. 15. – №. 2. – С. 32-33.